Abstract
The epidemic of poliomyelitis which occurred in Israel in 1958 among a population a large proportion of which had received inactivated Salk-type vaccine aroused great interest. This was the first time a vaccinated infant population had been exposed to a severe epidemic and thus afforded the first opportunity to determine whether or not vaccination afforded a high degree of protection in this age-group. The authors report on the observations made.
While the vaccine conferred some protection, this was not of so high a degree as had been expected from experience elsewhere in older children. This partial failure may be explained in part by the use in the earlier vaccination campaigns of vaccines of lower potency than is now current and perhaps by the fact that many vaccinations were performed intradermally.
No very exact measure of the protection conferred can be given. For some groups the figures are too small for statistical validity; for others, it is not possible to distinguish between the effect of vaccine and that of age, the latter possibly being the more important factor.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- ADLER E., ELIAKIM C., MAGORA A. Poliomyelitis in Jerusalem in 1953. Acta Med Orient. 1955 Jun;14(6):147–163. [PubMed] [Google Scholar]
- BENJAMIN B., LOGAN W. P. Geographical and social variations in the incidence of notified poliomyelitis. Br J Prev Soc Med. 1953 Jul;7(3):131–140. doi: 10.1136/jech.7.3.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BERNKOPF H. Isolation and identification of strains of poliomyelitis in tissue cultures. Harefuah. 1954 Nov 15;47(10):203–205. [PubMed] [Google Scholar]
- BERNKOPF H., LEVINE S. Poliomyelitis Lansing antibodies in three population groups in Israel. Bull World Health Organ. 1955;12(4):677–685. [PMC free article] [PubMed] [Google Scholar]
- BERNKOPF H., MEDALIE J., YEKUTIEL M. Antibodies to poliomyelitis virus and socioeconomic factors influencing their frequency in children in Israel. Am J Trop Med Hyg. 1957 Jul;6(4):697–703. doi: 10.4269/ajtmh.1957.6.697. [DOI] [PubMed] [Google Scholar]
- DAVIES M. [Poliomyelitis in Israel in the middle of 1958]. Harefuah. 1958 Jul 15;55(2):40–passim. [PubMed] [Google Scholar]
- GOFFE A. P., PARFITT E. M. Quarantine measures in poliomyelitis. Lancet. 1955 Jun 4;268(6875):1172–1175. doi: 10.1016/s0140-6736(55)90669-3. [DOI] [PubMed] [Google Scholar]
- GOLDBLUM N., GOTLIEB T., MILLER G. Production of formalinized poliomyelitis vaccine (Salk-type) on a semi-industrial scale. Bull World Health Organ. 1957;17(6):1001–1023. [PMC free article] [PubMed] [Google Scholar]
- HILL A. B., KNOWELDEN J. Inoculation and poliomyelitis; a statistical investigation in England and Wales in 1949. Br Med J. 1950 Jul 1;2(4669):1–6. doi: 10.1136/bmj.2.4669.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NATHAN T. [Poliomyelitis in the Negev]. Harefuah. 1959 Feb 15;56(4):84–92. [PubMed] [Google Scholar]
- PAUL J. R., HORSTMANN D. M. A survey of poliomyelitis virus antibodies in French Morocco. Am J Trop Med Hyg. 1955 May;4(3):512–524. doi: 10.4269/ajtmh.1955.4.512. [DOI] [PubMed] [Google Scholar]
- PAUL J. R., MELNICK J. L., BARNETT V. H., GOLDBLUM N. A survey of neutralizing antibodies to poliomyelitis virus in Cairo, Egypt. Am J Hyg. 1952 May;55(3):402–413. doi: 10.1093/oxfordjournals.aje.a119532. [DOI] [PubMed] [Google Scholar]
- PAYZIN S., MURRAY E. S. Note on antibodies to poliomyelitis viruses in the sera of residents of Eastern Saudi Arabia. Am J Trop Med Hyg. 1957 Jul;6(4):704–706. doi: 10.4269/ajtmh.1957.6.704. [DOI] [PubMed] [Google Scholar]
- ROTEM Y., CHIGIER E., RANNON L. Intermittent positive pressure respiration in infants with poliomyelitis. Acta Paediatr. 1958 Jul;47(4):418–427. doi: 10.1111/j.1651-2227.1958.tb07654.x. [DOI] [PubMed] [Google Scholar]
- ROTEM Y. [The clinical picture of poliomyelitis after the inoculation program]. Harefuah. 1959 Feb 15;56(4):79–84. [PubMed] [Google Scholar]
- SALK J. E. How many injections of poliomyelitis vaccine for effective and durable immunity. J Am Med Assoc. 1958 May 3;167(1):1–7. doi: 10.1001/jama.1958.02990180003001. [DOI] [PubMed] [Google Scholar]
- SUDIA W. D., CHAMBERLAIN R. W. The virus of St. Louis encephalitis in chickens. Am J Hyg. 1959 Sep;70:197–207. doi: 10.1093/oxfordjournals.aje.a120070. [DOI] [PubMed] [Google Scholar]
- THORN N. A., MILEWSKI B. Effect of leucine-vasopressin (phenylalanine-oxytocin) on renal excretion of Na and K in hydrated rats and dogs. Proc Soc Exp Biol Med. 1959 Feb;100(2):267–269. doi: 10.3181/00379727-100-24595. [DOI] [PubMed] [Google Scholar]
- TULINIUS S., HENNINGSEN E. J. Polio vaccination in Denmark April-June 1955. II. Organization and procedure for the school vaccination. Dan Med Bull. 1955 Dec;2(8):233–235. [PubMed] [Google Scholar]
- VON MAGNUS H., VON MAGNUS P., PETERSEN I., GODTFREDSEN A., RONKJAER M. Polio vaccination in Denmark in April-June 1955. I. The production of formalinized poliovaccine and preliminary results. Dan Med Bull. 1955 Dec;2(8):226–233. [PubMed] [Google Scholar]
- YEKUTIEL P., LEVINGER E. L., MUHSAM H. V., YEKUTIEL M. P. Poliomyelitis outbreak in Israel, 1950-1. Bull World Health Organ. 1955;12(4):651–676. [PMC free article] [PubMed] [Google Scholar]
- YEKUTIEL P., MARBERG K., GOLDBLUM N., LEVINE S. [Results of immunization against poliomyelitis in Israel during 1957]. Harefuah. 1958 May 1;54(9):225-6; English & French abstracts, 226. [PubMed] [Google Scholar]